92479 ⎘
Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing condensed ring systems
PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION
#2FACILE DIRECT AMINATION AND ALKYLAMINATION OF CARBON NANOTUBES
#3LIPID NANOMATERIALS AND USES THEREOF
#4COMPOSITIONS AND METHODS RELATED TO BICYCLO[2.2.1] HEPTANAMINE-CONTAINING COMPOUNDS
#5Method for preparing amantadine
#6Compositions and methods related to di-substituted bicyclo[2.2.1] heptanamine-containing compounds
#7CARBORANE-BASED HISTONE DEACETYLASE (HDAC) INHIBITORS
#8Platform drug delivery system utilizing crystal engineering and theanine dissolution
#9Continuous flow processes for making bicyclic compounds
#10Memantine paroxetine cocrystal salt and its preparation method, pharmaceutical composition and application
#11Analgesic compounds
#12Donezil pamoate, method of preparation and use thereof
#13Pamoate salts and methods of use
#14Nicotinic receptor non-competitive antagonists
#15Bicyclic compounds
#16Amantadine nitrate compounds for use as medicaments for the treatment of diseases
#17Nicotinic receptor non-competitive antagonists
#18Exo-S-mecamylamine formulation and use in treatment
#19Amantadine nitrate compounds with neural protective effect, and preparation and medical use thereof
#20Memantine pamoate, method of preparation and use thereof
#21(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
#22Salts of Prostaglandin Analog Intermediates
#23DERIVATIVES OF BETULIN
#24Compounds and compositions for treating HIV with derivatives of Betulin
#25Compounds Which Have a Protective Activity with Respect to the Action of Toxins and of Viruses with an Intracellular Mode of Action
#26(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
#27Bicyclic alkyl compounds and synthesis
#28Chemical compounds derived from normemantine and use of same in the medical field
#29Bicyclic compounds
#30Nicotinic receptor non-competitive antagonists
#31Antiviral compounds
#32Preparation method of aldehyde compound with limited amount of acrylonitrile
#33Preparation method of aldehyde compound using a metal compound and a phosphorus compound
#34Derivatives of Betulin
#35Compounds that are S1P modulating agents and/or ATX modulating agents
#36Compounds that are S1P modulating agents and/or ATX modulating agents
#37Inhibitors targeting drug-resistant influenza A
#38(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
#39COMPOUNDS FOR TREATING PARVOVIRUS INFECTION
#40Fungicidal N-bicycloalkyl and N-tricycloalkyl pyrazole-4-(thio)carboxamide derivatives
#41Donepezil pamoate, method of preparation and use thereof
#42NICOTINIC RECEPTOR NON-COMPETITIVE ANTAGONISTS
#43NICOTINIC RECEPTOR NON-COMPETITIVE MODULATORS
#44NICOTINIC RECEPTOR NON-COMPETITIVE ANTAGONISTS
#45(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS
#46Exo-S-mecamylamine formulation and use in treatment
#47Inhibitors of the influenza A virus M2 proton channel
#48PROCESS FOR THE PREPARATION OF ROTIGOTINE
#49Geranyl geranyl acetone (GGA) derivatives and compositions thereof
#50Adamantane derivatives possessing anti-viral and anti-microbial activity
#51Nicotinic receptor non-competitive antagonists
#52DRUGS, DERIVATIVES AND ANALOGS CONTAINING ADAMANTANE STRUCTURES OF NEW INDICATION APPLICATIONS OF ANTI-TUMOR
#53Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
#54Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
#55Inhibitors of the influenza A virus M2 proton channel
#56PROCESS FOR THE PREPARATION OF 1-BROMO-3,5-DIMETHYL ADAMANTANE
#57METHOD FOR PRODUCING MEMANTINE
#58PROCESS FOR PREPARING MEMANTINE
#59Process for manufacturing adamantane derivatives with high yield
#60Process for the preparation of rotigotine
#61Inhibitors of the Shiga toxins trafficking through the retrograde pathway
#62Platinum complex and pharmaceutical composition containing the same
#63Polymerizable higher diamondoid derivatives
#64SALTS OF MEMANTINE AND COX-INHIBITORS AND THEIR CRYSTAL FORM IN THE TREATMENT OF PAIN
#65Methods of use of antiviral compounds
#66METHODS OF USE OF ANTIVIRAL COMPOUNDS
#67EXO-S-MECAMYLAMINE FORMULATION AND USE IN TREATMENT
#68Process for preparing a primary amine with a tertiary alpha carbon atom by reacting a tertiary alcohol with ammonia
#69Exo-S-mecamylamine formulation and use in treatment
#70METHOD FOR SALT PREPARATION
#71Novel compounds
#72C-H bond amination and olefin aziridination with β-diketiminato copper catalysts
#73Process for the Preparation of Adamantanamines
#74REDUCING CARBOHYDRATE DERIVATIVES OF ADAMANTANE AMINES, AND SYNTHESIS AND METHODS OF USE THEREOF
#75Invention Concerning Aminoadamantane Compounds
#76Modified cyclic aliphatic polyamine
#77Process for preparing memantine hydrochloride substantially free of impurities
#78Diamondoid derivatives possessing therapeutic activity in the treatment of neurologic disorders
#79Method of preparing memantine hydrochloride
#80Salts of omeprazole and esomeprazole I
#81Exo-S-Mecamylamine Formulation and Use in Treatment
#82Process for synthesising aminoadamantanes
#83Diamondoid derivatives possessing therapeutic activity in the treatment of neurologic disorders
#84Polymorphs of memantine hydrochloride
#85Reducing carbohydrate derivatives of adamantane amines, and synthesis and methods of use thereof
#86Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride
#87Polymerizable higher diamondoid derivatives
#88Methods and compositions comprising diamines as new anti-tubercular therapeutics
#89Composition, synthesis and therapeutic applications of polyamines
#90Polyisocyanate compound, method for producing the same, and uses thereof